Human Reproductive Technologies Market by Product Types – Infertility Drugs – Gonal-F (Recombinant Follitropin Alfa), Follistim AQ (Follitropin Beta), Androgel (Testosterone), Testim (Testosterone), Viagra (Sildenafil Citrate), Cialis (Tadalafil), Levitra/Staxyn (Vardenafil), Infertility Procedure Types – In Vitro Fertilization, Intracytoplasmic Sperm Injection, Zygote Intrafallopian Transfer, Gamete Intrafallopian Transfer, Intrauterine Insemination, Contraceptive Technology, Drugs – oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives, and Devices – Male Contraceptive Devices (Male Condoms), and Female Contraceptive Devices and Forecast 2017-2021

Human Reproductive Technologies Market by Product Types – Infertility Drugs – Gonal-F (Recombinant Follitropin Alfa), Follistim AQ (Follitropin Beta), Androgel (Testosterone), Testim (Testosterone), Viagra (Sildenafil Citrate), Cialis (Tadalafil), Levitra/Staxyn (Vardenafil), Infertility Procedure Types – In Vitro Fertilization, Intracytoplasmic Sperm Injection, Zygote Intrafallopian Transfer, Gamete Intrafallopian Transfer, Intrauterine Insemination, Contraceptive Technology, Drugs – oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives, and Devices – Male Contraceptive Devices (Male Condoms), and Female Contraceptive Devices and Forecast 2017-2021

Human reproductive technology encompasses all current and anticipated uses of technology, including assisted reproductive technology, contraception and others. Assisted reproductive technology (ART) is used to achieve pregnancy in procedures such as fertility medication, artificial insemination, in vitro fertilization and surrogacy, and it is primarily used for infertility treatments. It mainly belongs to the field of reproductive endocrinology and infertility, and may also include intracytoplasmic sperm injection (ICSI) and cryopreservation.

The global human reproductive technologies market report provides market size (Revenue USD Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021).

The global human reproductive technologies market segmentation is based on product types such as Infertility Drugs – Gonal-F (Recombinant Follitropin Alfa), Follistim AQ (Follitropin Beta), Androgel (Testosterone), Testim (Testosterone), Viagra (Sildenafil Citrate), Cialis (Tadalafil), Levitra/Staxyn (Vardenafil), Infertility Procedure Types – In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Zygote Intrafallopian Transfer (ZIFT), Gamete Intrafallopian Transfer (GIFT), Intrauterine Insemination (IUI), Contraceptive Technology, Drugs – Oral Contraceptive Pills, Contraceptive Injectables, Topical Contraceptives, and Devices – Male Contraceptive Devices (Male Condoms), and Female Contraceptive Devices.

The global human reproductive technologies market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global human reproductive technologies market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

Category:
  1. Introduction
  2. Executive Summary
    • Market Size Estimation (Revenue USD Million, 2014-2021)
    • Forecast Estimation (Revenue USD Million and CAGR%, 2017-2021)
  3. Research Methodology
  4. Market Landscape
    • Market Dynamics
      • Drivers
      • Barriers
      • Opportunities
    • Market Share Analysis
      • Companies
      • Devices
    • Market Trends Analysis
      • Key success factors
      • Market Growth Rate
    • Market Attractiveness Analysis
    • Market Profitability Analysis
      • Buyer power
      • Supplier power
      • Barriers to entry
      • Threat of substitute products
      • Rivalry among firms in the industry
    • Distribution Channels
  5. Market Segmentation [refer Market Segments and Companies Tab]
    • Device or Brand Type
    • Diagnostic Test
    • Indication Type
    • Technology
    • Diagnostics, Therapeutic or Surgical Application
    • End User Groups
  6. Geography (Region, Country)
    • North America (U.S., Canada)
    • Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    • Latin America (Brazil, Mexico, Rest of LA)
    • Asia Pacific (Japan, China, India, Rest of APAC)
    • Rest of the World (Middle East & Africa)
  7. Regulatory Overview 
    • Device Classification I, II, III, IV
    • Device (FDA, EMEA) Approvals
  8. Company Profiles [refer Market Segments and Companies Tab]
    • Company Overview
    • Financial Snapshot (FY 2014-2016)
    • Product Portfolio
    • Business Strategies
    • Recent Developments
  9. Recommendations
  10. References

Human Reproductive Technologies Market

1. Infertility Drugs
1.1. Gonal-F (Recombinant Follitropin Alfa)
1.2. Follistim AQ (Follitropin Beta)
1.3. Androgel (Testosterone)
1.4. Testim (Testosterone)
1.5. Viagra (Sildenafil Citrate)
1.6. Cialis (Tadalafil)
1.7. Levitra/Staxyn (Vardenafil)

2. Infertility Procedure Type
2.1. In Vitro Fertilization (IVF)
2.2. Intracytoplasmic Sperm Injection (ICSI)
2.3. Zygote Intrafallopian Transfer (ZIFT)
2.4. Gamete Intrafallopian Transfer (GIFT)
2.5. Intrauterine Insemination (IUI)
2.6. Contraceptive Technology

3. Drugs
3.1. Oral Contraceptive Pills
3.2. Contraceptive Injectables
3.3. Topical Contraceptives

4. Devices
4.1. Male Contraceptive Devices (Male Condoms)
4.2. Female Contraceptive Devices

5. Geography (Region, Country)
5.1. North America (U.S., Canada)
5.2. Latin America (Brazil, Mexico, Rest of LA)
5.3. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
5.4. Asia Pacific (Japan, China, India, Rest of APAC)
5.5. Rest of the World

6. Company Profiles
6.1. Abbott Laboratories, Inc.
6.2. Actavis, Inc.
6.3. Bayer AG
6.4. Church & Dwight, Co. Inc.
6.5. Cook Medical, Inc.
6.6. Ferring International Center S.A.
6.7. Johnson & Johnson
6.8. Merck & Co., Inc.
6.9. Merck Serono
6.10. Pfizer, Inc.
6.11. Reckitt Benckiser Group plc
6.12. Teva Pharmaceutical Industries Ltd.
6.13. Warner Chilcott plc

Request market specific full ToC and sample pages for this report

Full Name*

Email*

Phone Number* [Please add country code]

Subject*

Message*

Translate »